Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence
Immunoglobulins (IGs) are widely used for the treatment of immunodeficiency syndromes and several autoimmune diseases. In neonates, IGs have been used for the treatment of alloimmune thrombocytopenia, in neonatal infections and in the rare cases of neonatal Kawasaki disease. This review aims to exam...
Main Authors: | Iftekhar Mahmood, Million A. Tegenge, Basil Golding |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/9/2/24 |
Similar Items
-
A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey
by: Iftekhar Mahmood
Published: (2021-09-01) -
A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule
by: Iftekhar Mahmood
Published: (2022-10-01) -
INFLUENCE OF HIGH CORTISOL DOSES UPON THE SERUM IMMUNOGLOBULIN LEVEL
by: Voja Pavlovic, et al.
Published: (2001-01-01) -
Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats
by: Deman Najar, et al.
Published: (2018-08-01) -
Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
by: Xiangge Ren, et al.
Published: (2024-03-01)